<code id='034540890B'></code><style id='034540890B'></style>
    • <acronym id='034540890B'></acronym>
      <center id='034540890B'><center id='034540890B'><tfoot id='034540890B'></tfoot></center><abbr id='034540890B'><dir id='034540890B'><tfoot id='034540890B'></tfoot><noframes id='034540890B'>

    • <optgroup id='034540890B'><strike id='034540890B'><sup id='034540890B'></sup></strike><code id='034540890B'></code></optgroup>
        1. <b id='034540890B'><label id='034540890B'><select id='034540890B'><dt id='034540890B'><span id='034540890B'></span></dt></select></label></b><u id='034540890B'></u>
          <i id='034540890B'><strike id='034540890B'><tt id='034540890B'><pre id='034540890B'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:6121

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          Wikipedia

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Mirador, a new biotech startup, launches with $400 million
          Mirador, a new biotech startup, launches with $400 million

          AdobeWhathappensafteryoucloseanearly$11billionacquisition?Well,forPrometheusTherapeutics’formerCEOMa

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          AltruBio raises $225 million to develop ulcerative colitis drug

          Micrographofchronicactiveulcerativecolitisinabiopsyspecimen.WikimediaCommonsCheckpointinhibitors,dru